Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Benchmark Downgrades Danaher to Hold

Benchmark Downgrades Danaher to Hold

Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.

byBenzinga Newsdesk

October 24, 2022

1 minute read

Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.

Tucker Carlson To Establish New Media Company On Back Of Elon Musk’s Twitter: WSJ

By Benzinga Neuro

July 14, 6:42 AM

Former Fox News host Tucker Carlson and former White House adviser Neil Patel are reportedly in the process…

FOX

Zhihu Reported Q1 Average Monthly Active Users (MAUs) of 89.0M, Average Monthly Subscribing Members of 14.8M

By Benzinga Newsdesk

June 12, 5:18 AM

First Quarter 2024 Highlights Total revenues were RMB960.9 million (US$133.1 million) in the first quarter of 2024, compared with RMB994.2 million in the same period of

Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio

By Vandana Singh

August 23, 6:16 AM

Alcon AG (NYSE:ALC) has agreed to acquire Aerie Pharmaceuticals Inc (NASDAQ:AERI) for $15.25 per share, valuing Aerie at about $770 million. The…

AERI

Why Is Philips Stock Trading Lower Today?

By Vandana Singh

November 29, 11:12 AM

Tuesday, the FDA issued a warning to patients and healthcare providers to carefully monitor

PHG

Benchmark Downgrades Danaher to Hold

Related Posts

Tucker Carlson To Establish New Media Company On Back Of Elon Musk’s Twitter: WSJ

Zhihu Reported Q1 Average Monthly Active Users (MAUs) of 89.0M, Average Monthly Subscribing Members of 14.8M

Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio

Why Is Philips Stock Trading Lower Today?